AARTI PHARMALABS
Back to Balance Sheet
|
AARTI PHARMALABS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹2,906 Cr | ₹2,582 Cr | ₹2,244 Cr | ₹2,040 Cr | ₹0.25 Cr |
What is the latest Total Liabilities ratio of AARTI PHARMALABS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹2,906 Cr |
| Mar2024 | ₹2,582 Cr |
| Mar2023 | ₹2,244 Cr |
| Mar2022 | ₹2,040 Cr |
| Mar2021 | ₹0.25 Cr |
How is Total Liabilities of AARTI PHARMALABS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,906 Cr | 12.56 | |
| Mar2024 | ₹2,582 Cr | 15.07 | |
| Mar2023 | ₹2,244 Cr | 10.01 | |
| Mar2022 | ₹2,040 Cr | 815,860.00 | |
| Mar2021 | ₹0.25 Cr | - | |
Compare Total Liabilities of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹6,113.6 Cr | -0% | -4% | -28% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹480,047.0 Cr | 3.1% | 7.2% | 18.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹208,141.0 Cr | 8.2% | 19.8% | 17.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,264.0 Cr | -1.8% | 4.9% | 37.2% | Stock Analytics | |
| CIPLA | ₹118,430.0 Cr | 3.9% | 0.6% | 0% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,516.1 Cr | -0.7% | -14.6% | -8.4% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | -0% |
-4% |
-28% |
| SENSEX | 2% |
1.9% |
-5.2% |
You may also like the below Video Courses